Healthtech Startups

1 investor

Digital therapeutics developer behind Stanza, an FDA-authorized smartphone behavioral therapy for fibromyalgia symptoms.

1 investor

Swiss Precision Active is an eco-conscious apparel brand that designs and manufactures medical scrubs, uniforms, and accessories using high-performance, sustainable textiles. It targets healthcare and uniform markets with a focus on fit, comfort, and environmentally minded materials.

1 investor

Swiss Rockets Group is an umbrella company that incubates and accelerates a portfolio of biotech startups working from late-stage pre-clinical through clinical development. It focuses on developing medicines to treat cancer, infectious diseases, and autoimmune disorders.

1 investor

1 investor

Sycai Technologies develops AI software for automated detection and follow-up monitoring of abdominal lesions in medical imaging to support early cancer diagnosis. The platform integrates into hospital radiology systems to assist radiologists in standardizing diagnostic workflows and reducing diagnostic errors.

1 investor

Sygen Pharmaceuticals is a life sciences company that manufactures medicines across more than 16 product categories in ISO- and NAFDAC-approved facilities. Established in 2019 and built on the acquired assets of Nigerian German Chemicals PLC, it focuses on the West African region.

1 investor

SymPhysis Medical develops medical devices to treat malignant pleural effusion, a complication affecting late-stage cancer patients. The company's technology, releaze™, is a drainage device designed to improve patient independence and quality of life.

1 investor

Symplast provides practice management and business intelligence software designed specifically for aesthetic medicine and plastic surgery practices. The platform combines administrative tools, patient engagement features, and practice analytics to help aesthetic physicians reduce operational burden and focus on patient care.

1 investor

Synapse, part of Capgemini Invent, provides design and technology innovation services focused on sustainability and climate solutions. The company helps clients reduce product carbon footprints, develop climate technologies, and build circular economy capabilities across energy, transportation, agriculture, and built environments.

1 investor

Synapsis Medical is a stealth-mode company in the medical technology space, working with OEM partners and clinical institutions, with detailed information only available under NDA.

1 investor

Synaptic works on a platform focused on improving arrhythmia and related cardiac disease outcomes. The company frames its work around supporting patient outcomes in a holistic manner.

1 investor

Synartro is a clinical-stage Swedish life science company developing intra-articular injection treatments that chemically bind proven drugs to a patented hyaluronan-based local injection technology for sustained drug release without systemic side effects. Its lead candidate SYN321, a slow-release diclofenac injection, is in development as a second-line treatment for symptomatic knee osteoarthritis.

1 investor

SynCardia manufactures the world's first commercially approved total artificial heart for patients with end-stage heart failure awaiting transplant. The company develops and delivers mechanical circulatory support devices as alternatives to heart transplantation for critically ill patients.

1 investor

KEWS300 is a hospital ward management system that displays real-time patient vital signs, staff assignments, and early-warning scores on a central station screen to help nurse managers optimize ward operations and patient care. The platform enables quick monitoring of nurse workloads and patient acuity across all admitted patients.

1 investor

SynDaver designs and manufactures synthetic humans and anatomical simulators made from water, salts, and fibers that replicate living tissue including muscles, bones, organs, and vessels. Its products serve medical device manufacturers, hospitals, medical and educational institutions, government and military bodies, and industrial customers for uses such as surgical training, medical device testing, education, and product/armor testing.

1 investor

1 investor

synedra develops IT infrastructure and software for healthcare institutions, including PACS imaging, a clinical data repository (CDR), and tools for point-of-care diagnostics and digital clinical workflows. It serves hospitals and clinics in German-speaking markets such as Austria, Germany, and Switzerland.

1 investor

Synergia Medical develops optoelectronic implantable medical devices, including its NAO.VNS vagus nerve stimulation system, which is undergoing First-In-Human clinical evaluation through the AURORA study. The company is based in Belgium.

1 investor

Synergy Disc is a medical device company developing motion-preserving spine technologies to treat degenerative disc disease, with a focus on preserving motion and improving sagittal alignment for spine surgery patients. Its flagship offering is an FDA-approved artificial cervical disc.

1 investor

SYNERGY HomeCare is a home care franchise network providing non-medical in-home care services including senior care, specialized care for disabilities, memory care, and hospital-to-home transitional services across the United States. The company operates over 210 franchises in more than 450 locations and employs direct caregivers who receive background checks and training.

1 investor

Synergy provides in-home video electroencephalogram (EEG) testing services for neurological diagnosis, delivering hospital-grade accuracy to patients' homes. The company serves physicians and healthcare organizations seeking diagnostic neurocare services.

1 investor

Synergy Spine Solutions develops motion-preserving medical devices for patients undergoing spine surgery to treat degenerative disc disease. The company's FDA-approved flagship product, the Synergy Disc, features a built-in lordotic core designed to preserve spinal motion and improve alignment.

1 investor

SYNLAB provides medical diagnostic and laboratory testing services covering disease prevention, diagnosis, treatment monitoring, and follow-up for patients and the medical community. It operates through a network of specialists across more than 20 countries.

1 investor